Alcalá-Cerra G, Paternina-Caicedo A J, Moscote-Salazar L R, Gutiérrez-Paternina J J, Niño-Hernández L M
Grupo de Investigación en Ciencias de la Salud y Neurociencias (CISNEURO), Cartagena de Indias, Colombia; Departamento de Neurocirugía, Universidad de Cartagena, Cartagena de Indias, Colombia.
Grupo de Investigación en Ciencias de la Salud y Neurociencias (CISNEURO), Cartagena de Indias, Colombia.
Rev Esp Cir Ortop Traumatol. 2014 May-Jun;58(3):182-91. doi: 10.1016/j.recot.2013.10.004. Epub 2014 Apr 2.
To determine the effects of applying vancomycin powder within the surgical wound on the risk of surgical infections, pseudo-arthrosis and adverse events, in patients undergoing spinal surgery.
A meta-analysis was carried out, including controlled studies that evaluated the risk of postoperative infections and/or pseudo-arthrosis in patients undergoing spinal surgery in which vancomycin powder was applied within the surgical wound.
were presented as pooled relative risks, with its 95% confidence intervals. Additionally, the frequency of complications attributable to vancomycin was also assessed.
A total of six controlled studies (3,379 subjects) were included. Pooled relative risks were: surgical site infection, 0.11 (95%CI: 0.05-0.25; P<.00001), and pseudo-arthrosis, 0.87 (95%CI; 0.34-2.21; P=.77). No statistically significant heterogeneity was found in both analyses. In 1,437 patients treated with vancomycin, there were no recorded vancomycin-related adverse events.
Application of vancomycin powder into the wound was associated with a significantly reduced risk of surgical site infections, without increasing pseudo-arthrosis or adverse events. However, randomized controlled trials are needed, in order to confirm the present results and make recommendations with more certainty.
确定在脊柱手术患者的手术伤口内应用万古霉素粉末对手术感染、假关节形成及不良事件风险的影响。
进行一项荟萃分析,纳入评估在手术伤口内应用万古霉素粉末的脊柱手术患者术后感染和/或假关节形成风险的对照研究。
以合并相对风险及其95%置信区间呈现。此外,还评估了万古霉素所致并发症的发生率。
共纳入六项对照研究(3379名受试者)。合并相对风险为:手术部位感染,0.11(95%置信区间:0.05 - 0.25;P <.00001),假关节形成,0.87(95%置信区间:0.34 - 2.21;P = 0.77)。两项分析均未发现统计学上的显著异质性。在1437例接受万古霉素治疗的患者中,未记录到与万古霉素相关的不良事件。
在伤口内应用万古霉素粉末与手术部位感染风险显著降低相关,且未增加假关节形成或不良事件的发生。然而,需要进行随机对照试验以证实目前的结果并更确切地提出建议。